Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|
Total Revenue | 182 | 306 | 515 | 435 |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | 182 | 306 | 515 | 435 |
Operating Expenses | ||||
Research Development | 947 | (779) | 2,224 | 1,915 |
Selling General and Administrative | 1,190 | (1,370) | 1,451 | 1,228 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | (5) | 0 |
Total Operating Expenses | 2,137 | (2,149) | 3,671 | 3,143 |
Operating Income or Loss | (1,955) | (1,843) | (3,156) | (2,707) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (7) | 34 | 4 | (24) |
Earnings Before Interest And Taxes | (1,968) | 2,420 | (3,160) | (2,683) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (1,948) | 1,172 | (3,505) | (2,691) |
Income Tax Expense | -- | -- | (77) | -- |
Minority Interest | (328) | (328) | (328) | (327) |
Net Income From Continuing Ops | (1,968) | 1,172 | (3,504) | (2,690) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | (4,289) | 1 | 0 |
Net Income | (1,968) | (3,117) | (3,503) | (2,690) |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | (1,968) | (3,117) | (3,504) | (2,690) |